Scholarly Index
Jennifer K. Litton
The University of Texas MD Anderson Cancer Center; 22,230 total citations; 392 total publications; best world rank #76
The University of Texas MD Anderson Cancer Center
22,230Total citations
392Total publications
66H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| BRCA gene mutations in cancer | Lifetime | 150 | US 83 | 98.69 |
| PARP inhibition in cancer therapy | Lifetime | 98 | US 47 | 98.50 |
| Breast Cancer Treatment Studies | Lifetime | 476 | US 229 | 98.57 |
| Cancer Genomics and Diagnostics | Lifetime | 909 | US 472 | 98.41 |
| Advanced Breast Cancer Therapies | Lifetime | 206 | US 101 | 98.28 |
| Multiple and Secondary Primary Cancers | Lifetime | 334 | US 141 | 96.68 |
| Cancer Risks and Factors | Lifetime | 421 | US 219 | 97.18 |
| Breast Lesions and Carcinomas | Lifetime | 903 | US 396 | 94.79 |
| Nutrition, Genetics, and Disease | Lifetime | 824 | US 350 | 92.14 |
| BRCA gene mutations in cancer | 2021-2025 | 76 | US 36 | 96.76 |
| PARP inhibition in cancer therapy | 2021-2025 | 86 | US 36 | 96.82 |
| Breast Cancer Treatment Studies | 2021-2025 | 494 | US 168 | 94.73 |
| Advanced Breast Cancer Therapies | 2021-2025 | 470 | US 168 | 91.26 |
| DNA Repair Mechanisms | 2021-2025 | 439 | US 187 | 86.36 |
| Breast Lesions and Carcinomas | 2021-2025 | 719 | US 207 | 77.16 |